Thanks to a new technology called Moscot (“Multi-Omics Single-Cell Optimal Transport”), researchers can now observe millions of cells simultaneously as they develop into a new organ—for example, a ...

This is a useful study that seeks to address the role of the TET family of DNA demethylation enzymes in pancreatic beta cell senescence in the context of type 2 diabetes (T2DM). Although the concepts ...

This manuscript describes the identification and characterization of 12 specific phosphomimetic mutations in the recombinant full-length human tau protein that trigger tau to form fibrils. This ...

Search for other works by this author on: 4Department of System Biology, Columbia University Irving Medical Center, New York, New York. 11Department of Molecular Pharmacology and Therapeutics, ...

Saifur Khan, Ph.D., cardiology research faculty member at the University of Pittsburgh Vascular Medicine Institute, is the first to identify molecular ... improve pancreatic beta cell function ...

Sapio Sciences, the science-aware™ lab informatics platform, today announced the launch of Release 24.12, introducing new tools for chemistry, molecular biology, GMP workflows, and immunogenicity.

Hill is now an assistant professor in molecular ... help restore pancreatic function in people with diabetes. But Hill cautions that treatments that help beta cells regenerate in mice historically ...

Beta Bionics plans for shares to be listed on the Nasdaq under the ticker symbol “BBNX.” The Irvine, California-based company makes an insulin pump called the iLet Bionic Pancreas, which was ...

Our Section aims to understand the function of metabolically relevant cell systems ... family in pancreatic islets and other relevant tissues, with direct application to the development of novel type ...

Beta Bionics’ filing follows a year with few IPOs. In 2024, just a handful of medtech companies went public, including Tempus AI in June, Ceribell in October and Anteris in December. The diabetes tech ...